Chartwell Investment Partners, LLC Kura Oncology, Inc. Transaction History

Chartwell Investment Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$11.78 - $16.98 $400,425 - $577,184	-33,992 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$12.22 - $19.57 $10,362 - $16,595	-848 Reduced 2.43%	33,992 $475,000
Q2 2021 Jul 19, 2021	BUY	$20.85 - $29.88 $6,713 - $9,621	322 Added 0.93%	34,840 $726,000
Q1 2021 May 03, 2021	SELL	$24.75 - $39.14 $45,911 - $72,604	-1,855 Reduced 5.1%	34,518 $976,000
Q4 2020 Feb 09, 2021	SELL	$29.0 - $41.62 $240,700 - $345,446	-8,300 Reduced 18.58%	36,373 $1.19 Million
Q2 2020 Jul 29, 2020	BUY	$7.95 - $18.81 $355,150 - $840,299	44,673 New	44,673 $728,000

187

81.9M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $529M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.